Akso Health Group (NASDAQ: AHG) Stock Competitors & Peer Comparison
See AHG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AHG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AHG | $0.76 | -5.21% | 687.4M | -3.77 | -$0.21 | N/A |
| MCK | $899.56 | -1.25% | 105.3B | 22.03 | $40.82 | +0.39% |
| COR | $323.29 | -0.90% | 62.9B | 18.85 | $17.15 | +0.75% |
| CAH | $232.65 | -0.95% | 54.5B | 22.30 | $10.43 | +0.87% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $87.52 | -1.59% | 10B | 16.48 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| EMPG | $17.36 | +0.00% | 143M | 192.89 | $0.09 | N/A |
| ACH | $1.13 | +0.45% | 86.2M | 1.65 | $0.68 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
AHG vs MCK Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, MCK has a market cap of 105.3B. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while MCK trades at $899.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas MCK's P/E ratio is 22.03. In terms of profitability, AHG's ROE is -0.50%, compared to MCK's ROE of -1.94%. Regarding short-term risk, AHG is more volatile compared to MCK. This indicates higher risk in terms of short-term price fluctuations for AHG.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
AHG vs COR Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, COR has a market cap of 62.9B. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while COR trades at $323.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas COR's P/E ratio is 18.85. In terms of profitability, AHG's ROE is -0.50%, compared to COR's ROE of +1.06%. Regarding short-term risk, AHG is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for AHG.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
AHG vs CAH Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, CAH has a market cap of 54.5B. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while CAH trades at $232.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas CAH's P/E ratio is 22.30. In terms of profitability, AHG's ROE is -0.50%, compared to CAH's ROE of -0.60%. Regarding short-term risk, AHG is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
AHG vs ABC Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas ABC's P/E ratio is 21.92. In terms of profitability, AHG's ROE is -0.50%, compared to ABC's ROE of +1.06%. Regarding short-term risk, AHG is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for AHG.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
AHG vs HSIC Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, HSIC has a market cap of 10B. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while HSIC trades at $87.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas HSIC's P/E ratio is 16.48. In terms of profitability, AHG's ROE is -0.50%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, AHG is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for AHG.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
AHG vs PDCO Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas PDCO's P/E ratio is 20.48. In terms of profitability, AHG's ROE is -0.50%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, AHG is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for AHG.Check PDCO's competition here
Owens & Minor, Inc. (NYSE: OMI)
AHG vs OMI Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas OMI's P/E ratio is -0.47. In terms of profitability, AHG's ROE is -0.50%, compared to OMI's ROE of +0.63%. Regarding short-term risk, AHG is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for AHG.Check OMI's competition here
Empro Group Inc. Ordinary shares (NASDAQ: EMPG)
AHG vs EMPG Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, EMPG has a market cap of 143M. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while EMPG trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas EMPG's P/E ratio is 192.89. In terms of profitability, AHG's ROE is -0.50%, compared to EMPG's ROE of +0.66%. Regarding short-term risk, AHG is more volatile compared to EMPG. This indicates higher risk in terms of short-term price fluctuations for AHG.Check EMPG's competition here
Accendra Health, Inc. (NYSE: ACH)
AHG vs ACH Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, ACH has a market cap of 86.2M. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while ACH trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas ACH's P/E ratio is 1.65. In terms of profitability, AHG's ROE is -0.50%, compared to ACH's ROE of +0.63%. Regarding short-term risk, AHG is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for AHG.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
AHG vs HX Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas HX's P/E ratio is -1.84. In terms of profitability, AHG's ROE is -0.50%, compared to HX's ROE of -1.07%. Regarding short-term risk, AHG is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for AHG.Check HX's competition here
111, Inc. (NASDAQ: YI)
AHG vs YI Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, YI has a market cap of 29.1M. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while YI trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas YI's P/E ratio is -2.38. In terms of profitability, AHG's ROE is -0.50%, compared to YI's ROE of +0.14%. Regarding short-term risk, AHG is more volatile compared to YI. This indicates higher risk in terms of short-term price fluctuations for AHG.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
AHG vs WGRX Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas WGRX's P/E ratio is -0.33. In terms of profitability, AHG's ROE is -0.50%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, AHG is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for AHG.Check WGRX's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
AHG vs MEDS Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, MEDS has a market cap of 4.3M. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while MEDS trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas MEDS's P/E ratio is N/A. In terms of profitability, AHG's ROE is -0.50%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, AHG is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for AHG.Check MEDS's competition here
Zynex, Inc. (NASDAQ: ZYXI)
AHG vs ZYXI Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, AHG's ROE is -0.50%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, AHG is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for AHG.Check ZYXI's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
AHG vs HKPD Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, HKPD has a market cap of 1.2M. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while HKPD trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas HKPD's P/E ratio is -1.85. In terms of profitability, AHG's ROE is -0.50%, compared to HKPD's ROE of -0.15%. Regarding short-term risk, AHG is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for AHG.Check HKPD's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
AHG vs SNYR Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, SNYR has a market cap of 856.5K. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while SNYR trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas SNYR's P/E ratio is -0.06. In terms of profitability, AHG's ROE is -0.50%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, AHG is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for AHG.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
AHG vs RDGT Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, RDGT has a market cap of 733.5K. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while RDGT trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas RDGT's P/E ratio is -0.02. In terms of profitability, AHG's ROE is -0.50%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, AHG is more volatile compared to RDGT. This indicates higher risk in terms of short-term price fluctuations for AHG.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
AHG vs CVET Comparison September 2026
Akso Health Group (NASDAQ: AHG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHG stands at 687.4M. In comparison, CVET has a market cap of 0. Regarding current trading prices, AHG is priced at $0.76 on the NASDAQ, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHG currently has a P/E ratio of -3.77, whereas CVET's P/E ratio is -69.97. In terms of profitability, AHG's ROE is -0.50%, compared to CVET's ROE of -0.06%. Regarding short-term risk, AHG is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for AHG.Check CVET's competition here